Education
About Us
Working with TipRanks
Follow Us
Baxter International (BAX)
NYSE:BAX
BAX Stock Chart & Stats
Day’s Range― - ―
52-Week Range$21.33 - $40.49
Previous CloseN/A
Volume899.70K
Average Volume (3M)8.84M
Market Cap
$12.61B
Enterprise Value$23.58B
Total Cash (Recent Filing)$2.29B
Total Debt (Recent Filing)$10.31B
Price to Earnings (P/E)136.1
Beta0.75
Next Earnings
Oct 30, 2025EPS Estimate
0.6Next Dividend Ex-Date
Aug 29, 2025Dividend Yield3.27%
Share Statistics
EPS (TTM)0.59
Shares Outstanding513,621,030
10 Day Avg. Volume6,474,417
30 Day Avg. Volume8,837,154
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap1.87
Enterprise Value/Revenue1.98
Enterprise Value/Gross Profit5.50
Enterprise Value/Ebitda36.44
Forecast
1Y Price Target
$28.00Price Target Upside14.29% Upside
Rating ConsensusHold
Number of Analyst Covering13
Bulls Say, Bears Say
Bulls Say
Business StreamliningThe company is becoming more streamlined and nimble to better take advantage of growth drivers.
Innovation And Product LaunchesManagement's strategic focus includes increasing investment in R&D to drive a steady cadence of innovative new product launches.
Operational GrowthHealthcare Systems & Technologies sales exceeded the Street's consensus estimate, showing operational growth.
Bears Say
Earnings PerformanceBaxter's shares have been downgraded from Buy to Neutral due to disappointing 2Q earnings results and revised 2025 guidance.
Growth OutlookBaxter’s disappointing 2Q25 performance, full-year guidance reduction, and thus, the 2025 outlook leave analysts feeling that the path to reliably-consistent mid-single-digit sales growth and more-meaningful margin expansion could take longer than previously thought.
Sales And Margin ChallengesSales softness in US Infusion Therapies & Technologies, along with manufacturing inefficiencies and an unfavorable product mix, contributed to a disappointing 2Q25 performance.
Baxter International News
BAX FAQ
What was Baxter International’s price range in the past 12 months?
Baxter International lowest stock price was $21.33 and its highest was $40.49 in the past 12 months.
What is Baxter International’s market cap?
Baxter International’s market cap is $12.61B.
When is Baxter International’s upcoming earnings report date?
Baxter International’s upcoming earnings report date is Oct 30, 2025 which is in 63 days.
How were Baxter International’s earnings last quarter?
Baxter International released its earnings results on Jul 31, 2025. The company reported $0.59 earnings per share for the quarter, missing the consensus estimate of $0.61 by -$0.02.
Is Baxter International overvalued?
According to Wall Street analysts Baxter International’s price is currently Undervalued.
Does Baxter International pay dividends?
Baxter International pays a Quarterly dividend of $0.17 which represents an annual dividend yield of 3.27%. See more information on Baxter International dividends here
What is Baxter International’s EPS estimate?
Baxter International’s EPS estimate is 0.6.
How many shares outstanding does Baxter International have?
Baxter International has 513,621,030 shares outstanding.
What happened to Baxter International’s price movement after its last earnings report?
Baxter International reported an EPS of $0.59 in its last earnings report, missing expectations of $0.61. Following the earnings report the stock price went down -22.424%.
Which hedge fund is a major shareholder of Baxter International?
Currently, no hedge funds are holding shares in BAX
Baxter International Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$28.00 (14.29% Upside)
$28.00 (14.29% Upside)
Blogger Sentiment
Bullish
BAX Sentiment 71%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 3.9M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▼ 1.9%
Last 30 Days ▲ 24.5%
Last 30 Days ▲ 24.5%
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-33.04%
12-Months-Change
Fundamentals
Return on Equity
-3.30%
Trailing 12-Months
Asset Growth
-20.01%
Trailing 12-Months
Company Description
Baxter International
Baxter International Inc. is a global healthcare company that specializes in the development, manufacturing, and marketing of a broad range of medical products. The company operates primarily in two segments: Hospital Products and Renal. Baxter's core products include intravenous (IV) solutions, infusion systems, and renal care products like dialysis equipment. The company is dedicated to improving patient outcomes and enhancing the safety and efficiency of healthcare delivery through innovative products and therapies.
BAX Company Deck
BAX Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call reflects a mixed performance with notable achievements in sales growth and operational efficiency, countered by significant challenges in product lines and lowered guidance due to external and internal factors.View all BAX earnings summariesBAX Net sales Breakdown
55.00% U.S.
32.31% ROW
12.69% Emerging markets
BAX Stock 12 Month Forecast
Average Price Target
$28.00
▲(14.29% Upside)
Technical Analysis
Ownership Overview
0.38% Insiders
34.47% Mutual Funds
32.57% Other Institutional Investors
4.63% Public Companies and
Individual Investors